OR Royalties (NYSE:OR) Rating Increased to Strong-Buy at Wall Street Zen

OR Royalties (NYSE:OR) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday.

OR has been the topic of a number of other research reports. Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price on the stock in a research report on Thursday, November 6th. Scotiabank lowered shares of OR Royalties from an “outperform” rating to a “sector perform” rating and increased their price objective for the stock from $33.00 to $41.00 in a research note on Thursday, October 23rd. Weiss Ratings restated a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Zacks Research downgraded OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Friday, December 19th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $38.00 price objective on shares of OR Royalties in a report on Sunday, December 7th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $35.75.

OR Royalties Price Performance

NYSE OR opened at $41.21 on Monday. The company has a market cap of $7.71 billion, a price-to-earnings ratio of 52.16 and a beta of 0.78. The stock’s fifty day moving average price is $35.49 and its 200 day moving average price is $33.66. OR Royalties has a 1 year low of $17.55 and a 1 year high of $42.25.

OR Royalties (NYSE:OR) last issued its quarterly earnings results on Wednesday, November 5th. The basic materials company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $71.63 million during the quarter, compared to analysts’ expectations of $53.85 million. OR Royalties had a return on equity of 10.67% and a net margin of 60.72%. Research analysts expect that OR Royalties will post 0.62 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in OR. Linden Thomas Advisory Services LLC lifted its position in shares of OR Royalties by 4.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 6,254 shares of the basic materials company’s stock valued at $221,000 after buying an additional 249 shares in the last quarter. Euro Pacific Asset Management LLC raised its position in OR Royalties by 0.7% during the fourth quarter. Euro Pacific Asset Management LLC now owns 1,028,079 shares of the basic materials company’s stock worth $36,088,000 after acquiring an additional 7,579 shares during the period. New England Professional Planning Group Inc. acquired a new position in OR Royalties during the fourth quarter worth $229,000. CWA Asset Management Group LLC lifted its holdings in OR Royalties by 7.1% during the fourth quarter. CWA Asset Management Group LLC now owns 408,918 shares of the basic materials company’s stock valued at $14,472,000 after purchasing an additional 27,171 shares in the last quarter. Finally, Swiss Life Asset Management Ltd acquired a new stake in shares of OR Royalties in the third quarter valued at about $355,000. 68.52% of the stock is owned by institutional investors and hedge funds.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.